Parian Global Management’s PAVmed PAVM Stock Holding History

Parian Global Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-630	Closed	-$2.42M	–	44
2021 Q3	$2.42M	Buy	+630	New	+$1.99M	1.69%	21
2021 Q2	–	Sell	-969	Closed	-$1.94M	–	51
2021 Q1	$1.94M	Buy	+969	New	+$1.46M	0.89%	24

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Parian Global Management's PAVM Position: Q4 2021 in Review

Parian Global Management sold out of PAVmed (PAVM) in Q4 2021, closing a stake of 630 shares — an estimated $2.42M sold.

Parian Global Management first reported a position in PAVM in Q1 2021 and held it in 2 quarters. The position peaked at $2.42M in Q3 2021. 105 funds tracked by Wall St. Rank hold PAVM as of Q4 2021.

Parian Global Management reported no remaining PAVmed position as of Q4 2021 after selling out during the quarter.
Parian Global Management sold 630 PAVmed shares in Q4 2021, an estimated $2.42M.
Parian Global Management first reported a position in PAVmed in Q1 2021 and held it in 2 quarters.
Parian Global Management's PAVmed position peaked at $2.42M in Q3 2021.
105 funds tracked by Wall St. Rank held PAVmed as of Q4 2021.

Based on Parian Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.